Cliff Asness’s Integra LifeSciences IART Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $4.64M | Buy |
258,159
+122,574
| +90% | +$1.71M | ﹤0.01% | 2057 |
|
|
2026
Q1 | $1.26M | Buy |
135,585
+16,114
| +13% | +$177K | ﹤0.01% | 2642 |
|
|
2025
Q4 | $1.48M | Sell |
119,471
-11,145
| -9% | -$148K | ﹤0.01% | 2325 |
|
|
2025
Q3 | $1.8M | Buy |
130,616
+22,658
| +21% | +$310K | ﹤0.01% | 2037 |
|
|
2025
Q2 | $1.32M | Buy |
107,958
+45,200
| +72% | +$656K | ﹤0.01% | 2032 |
|
|
2025
Q1 | $1.38M | Sell |
62,758
-1,028
| -2% | -$24.2K | ﹤0.01% | 1825 |
|
|
2024
Q4 | $1.45M | Sell |
63,786
-23,966
| -27% | -$523K | ﹤0.01% | 1692 |
|
|
2024
Q3 | $1.57M | Sell |
87,752
-524,046
| -86% | -$12.1M | ﹤0.01% | 1611 |
|
|
2024
Q2 | $17.4M | Buy |
611,798
+291,326
| +91% | +$8.64M | 0.03% | 620 |
|
|
2024
Q1 | $11.1M | Sell |
320,472
-226,731
| -41% | -$9.07M | 0.02% | 681 |
|
|
2023
Q4 | $23.8M | Sell |
547,203
-216,975
| -28% | -$8.54M | 0.04% | 447 |
|
|
2023
Q3 | $29.2M | Sell |
764,178
-50,710
| -6% | -$2.13M | 0.06% | 354 |
|
|
2023
Q2 | $33.5M | Buy |
814,888
+397,508
| +95% | +$19.1M | 0.07% | 320 |
|
|
2023
Q1 | $23.8M | Sell |
417,380
-10,348
| -2% | -$583K | 0.05% | 416 |
|
|
2022
Q4 | $23.9M | Sell |
427,728
-2,550
| -0.6% | -$130K | 0.05% | 412 |
|
|
2022
Q3 | $18.2M | Buy |
430,278
+166,335
| +63% | +$8.52M | 0.04% | 485 |
|
|
2022
Q2 | $14.3M | Buy |
263,943
+135,062
| +105% | +$8.11M | 0.03% | 586 |
|
|
2022
Q1 | $8.28M | Buy |
128,881
+43,393
| +51% | +$2.86M | 0.02% | 748 |
|
|
2021
Q4 | $5.73M | Buy |
85,488
+27,181
| +47% | +$1.84M | 0.01% | 800 |
|
|
2021
Q3 | $3.99M | Sell |
58,307
-17,135
| -23% | -$1.21M | 0.01% | 868 |
|
|
2021
Q2 | $5.15M | Sell |
75,442
-77,410
| -51% | -$5.47M | 0.01% | 837 |
|
|
2021
Q1 | $10.6M | Sell |
152,852
-55,007
| -26% | -$3.73M | 0.02% | 663 |
|
|
2020
Q4 | $13.5M | Sell |
207,859
-52,248
| -20% | -$2.81M | 0.02% | 546 |
|
|
2020
Q3 | $12.1M | Buy |
260,107
+116,842
| +82% | +$5.56M | 0.02% | 599 |
|
|
2020
Q2 | $6.62M | Buy |
+143,265
| New | +$7.04M | 0.01% | 721 |
|
|
2020
Q1 | – | Sell |
-99,571
| Closed | -$5.8M | – | 2093 |
|
|
2019
Q4 | $5.8M | Buy |
99,571
+13,822
| +16% | +$823K | 0.01% | 916 |
|
|
2019
Q3 | $5.15M | Buy |
85,749
+73,944
| +626% | +$4.41M | 0.01% | 964 |
|
|
2019
Q2 | $659K | Buy |
+11,805
| New | +$608K | ﹤0.01% | 1635 |
|
|
2018
Q2 | – | Sell |
-6,961
| Closed | -$385K | – | 2347 |
|
|
2018
Q1 | $385K | Hold |
6,961
| – | – | ﹤0.01% | 1989 |
|
|
2017
Q4 | $333K | Sell |
6,961
-10,683
| -61% | -$523K | ﹤0.01% | 2038 |
|
|
2017
Q3 | $891K | Sell |
17,644
-1,228
| -7% | -$63.1K | ﹤0.01% | 1713 |
|
|
2017
Q2 | $1.03M | Sell |
18,872
-10,044
| -35% | -$480K | ﹤0.01% | 1662 |
|
|
2017
Q1 | $1.22M | Sell |
28,916
-4,676
| -14% | -$200K | ﹤0.01% | 1588 |
|
|
2016
Q4 | $1.44M | Sell |
33,592
-1,706
| -5% | -$69.3K | ﹤0.01% | 1559 |
|
|
2016
Q3 | $1.46M | Buy |
35,298
+2,984
| +9% | +$125K | ﹤0.01% | 1570 |
|
|
2016
Q2 | $1.29M | Sell |
32,314
-2,400
| -7% | -$86.3K | ﹤0.01% | 1512 |
|
|
2016
Q1 | $1.17M | Sell |
34,714
-8,390
| -19% | -$261K | ﹤0.01% | 1515 |
|
|
2015
Q4 | $1.46M | Buy |
43,104
+9,176
| +27% | +$287K | ﹤0.01% | 1407 |
|
|
2015
Q3 | $1.01M | Buy |
33,928
+2,222
| +7% | +$69.5K | ﹤0.01% | 1420 |
|
|
2015
Q2 | $873K | Buy |
31,706
+17,272
| +120% | +$460K | ﹤0.01% | 1563 |
|
|
2015
Q1 | $364K | Buy |
+14,434
| New | +$341K | ﹤0.01% | 1806 |
|
Other funds holding IART
RCMNY
PCMI
Cliff Asness's IART Position: Q2 2026 in Review
Cliff Asness increased its Integra LifeSciences (IART) stake by 90% in Q2 2026, buying an estimated $1.71M and bringing the position to 258,159 shares worth $4.64M. The position accounts for ﹤0.01% of the portfolio, ranked #2057.
Cliff Asness first reported a position in IART in Q1 2015 and has held it in 41 quarters since. The position peaked at $33.5M in Q2 2023. 211 funds tracked by Wall St. Rank hold IART as of Q2 2026.
- Cliff Asness held 258,159 shares of Integra LifeSciences worth $4.64M as of Q2 2026.
- Cliff Asness bought 122,574 Integra LifeSciences shares in Q2 2026, an estimated $1.71M.
- Integra LifeSciences made up ﹤0.01% of Cliff Asness's portfolio in Q2 2026, its #2057 holding.
- Cliff Asness first reported a position in Integra LifeSciences in Q1 2015 and has held it in 41 quarters since.
- Cliff Asness's Integra LifeSciences position peaked at $33.5M in Q2 2023.
- 211 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2026.
Based on AQR Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.